NCT01025700

Brief Summary

Safety of Nabilone in reducing marijuana craving

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
35

participants targeted

Target at P25-P50 for phase_2

Timeline
Completed

Started Jun 2009

Shorter than P25 for phase_2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2009

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

December 2, 2009

Completed
1 day until next milestone

First Posted

Study publicly available on registry

December 3, 2009

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2010

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2010

Completed
Last Updated

February 17, 2011

Status Verified

February 1, 2011

Enrollment Period

1 year

First QC Date

December 2, 2009

Last Update Submit

February 16, 2011

Conditions

Marijuana Smoking

Keywords

EfficacyMarijuanaReductionCraving

Outcome Measures

Primary Outcomes (1)

  • Safety and tolerability to Nabilone

Secondary Outcomes (1)

  • Marijuana craving questionnaire

Study Arms (2)

Cesemat

EXPERIMENTAL
Drug: Cesemat

Placebo

NO INTERVENTION

Interventions

CesematDRUG

1 mg capsule per day for 21 days

Also known as: Nabilone
Cesemat

Eligibility Criteria

Age19 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years or older
  • History of marijuana use

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Vancouver General Hospital - Psychiatry Outpatient

Vancouver, British Columbia, Canada

Location

MeSH Terms

Conditions

Marijuana SmokingMarijuana Abuse

Interventions

nabilone

Condition Hierarchy (Ancestors)

Marijuana UseBehaviorSmoking, Non-Tobacco ProductsSmokingSubstance-Related DisordersChemically-Induced DisordersMental Disorders

Study Officials

  • Shaohua Lu, MD

    University of British Columbia

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

December 2, 2009

First Posted

December 3, 2009

Study Start

June 1, 2009

Primary Completion

June 1, 2010

Study Completion

October 1, 2010

Last Updated

February 17, 2011

Record last verified: 2011-02

Locations

CA(1)